US 11028126
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
granted A61KA61K2039/505A61K47/65
Quick answer
US patent 11028126 (Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof) held by CytomX Therapeutics, Inc. expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 54
- CPC classes
- A61K, A61K2039/505, A61K47/65, A61K47/6835, A61K47/6889